Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator More Proof That Time Is Brain

被引：27
|
作者：
Alberts, Mark J. [1 ]
机构：
[1] UT Southwestern Med Ctr, Dept Neurol, Dallas, TX USA
来源：
CIRCULATION | 2017年 / 135卷 / 02期
关键词：
Editorials; alteplase; cerebrovascular disorders; stroke; tissue plasminogen activator; FUNCTIONAL OUTCOMES; THROMBOLYSIS; DELAY;
D O I：
10.1161/CIRCULATIONAHA.116.025724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：140 / 142
页数：3
相关论文
共 50 条
  • [31] Is tissue-type plasminogen activator a neuromodulator?
    Fernández-Monreal, M
    López-Atalaya, JP
    Benchenane, K
    Léveillé, F
    Cacquevel, M
    Plawinski, L
    MacKenzie, ET
    Bu, GJ
    Buisson, A
    Vivien, D
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 25 (04) : 594 - 601
  • [32] TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    TURAZZA, FM
    POGNA, M
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1990, 10 (01): : 75 - 78
  • [33] Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model
    Vanderschueren, S
    VanVlaenderen, I
    Collen, D
    STROKE, 1997, 28 (09) : 1783 - 1788
  • [34] Re: Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers - response
    Johnston, SC
    STROKE, 2001, 32 (10) : 2440 - 2440
  • [35] Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers - The influence of ethnicity
    Johnston, SC
    Fung, LH
    Gillum, LA
    Smith, WS
    Brass, LM
    Lichtman, JH
    Brown, AN
    STROKE, 2001, 32 (05) : 1061 - 1067
  • [36] Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses
    Liao, Xiaoling
    Wang, Yilong
    Pan, Yuesong
    Wang, Chunjuan
    Zhao, Xingquan
    Wang, David Z.
    Wang, Chunxue
    Liu, Liping
    Wang, Yongjun
    STROKE, 2014, 45 (08) : 2354 - 2358
  • [37] Acute Stroke Shifting From Informed Consent to Informed Refusal of Intravenous Tissue-Type Plasminogen Activator
    Schwamm, Lee H.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (06): : S69 - S72
  • [38] The 4.5-Hour Time Window for Intravenous Thrombolysis With Intravenous Tissue-Type Plasminogen Activator Is Not Firmly Established
    Wechsler, Lawrence R.
    STROKE, 2014, 45 (03) : 914 - 915
  • [39] Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion
    Kattah, JC
    Wang, DZ
    Reddy, C
    ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (09) : 1234 - 1236
  • [40] Tissue-type plasminogen activator should not be used in acute ischemic stroke
    Riggs, JE
    ARCHIVES OF FAMILY MEDICINE, 1997, 6 (02) : 102 - 104
12345